NSPR May 2024 5.000 call
| Previous close | 0.3000 |
| Open | 0.3000 |
| Bid | 0.0500 |
| Ask | 0.5500 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.3000 - 0.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 77 |
GlobeNewswireInspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
-Conference call and webcast to be held at 8:30 a.m. EDT-TEL AVIV, Israel and MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report first quarter 2024 financial results on Tuesday, May 14th, before the financial markets open. Management will host a conference call and webcast with the investment community at 8:30
- GlobeNewswire
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024. Presentation details: Date:Wednesday, April 10th Time:8:00-8:40 AM ET Webcast:https://wsw.com/webcast/needham13
Simply Wall St.InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year
It hasn't been the best quarter for InspireMD, Inc. ( NASDAQ:NSPR ) shareholders, since the share price has fallen 16...
